Amanote Research

Amanote Research

    RegisterSign In

Prospective Evaluation of Analgesic Use and Risk of Renal Cell Cancer

Archives of Internal Medicine
doi 10.1001/archinternmed.2011.356
Full Text
Open PDF
Abstract

Available in full text

Date

September 12, 2011

Authors
Eunyoung Cho
Publisher

American Medical Association (AMA)


Related search

ABO Blood Group and Risk of Renal Cell Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

ABO Blood Group and Risk of Renal Cell Cancer

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2012English

Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses’ Health Studies

JAMA Oncology
Cancer ResearchOncology
2018English

Analgesic and Anti-Inflammatory Drug Use and Risk of Bladder Cancer: A Population Based Case Control Study

BMC Urology
MedicineReproductive MedicineUrology
2007English

Lifetime Nonnarcotic Analgesic Use and Decline in Renal Function in Women

Archives of Internal Medicine
2004English

Long-Term Analgesic Use After Low-Risk Surgery

Archives of Internal Medicine
2012English

Duration of Temporary Catheter Use for Hemodialysis: An Observational, Prospective Evaluation of Renal Units in Brazil

BMC Nephrology
Nephrology
2011English

Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2016English

Risk Factors for Renal Cell Cancer in a Japanese Population

Clinical medicine. Oncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy